Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
| Protocol Type | Tirzepatide Dose | 5-Amino-1MQ Dose | Administration Frequency | Expected Mechanism | Typical Observation Window | Professional Assessment | ||||||| | Tirzepatide Monotherapy | 2.515mg weekly (titrated) | None | Weekly subcutaneous injection | GLP-1/GIP receptor agonism reduces appetite and slows gastric emptying | 1220 weeks to plateau | Proven efficacy in human trials
However, this is often just moderate and will pass fast
This treatment is perfect for individuals looking for a noninvasive option to supplement their health and fitness goals
Be patient and realistic about the expected results, and communicate regularly with your healthcare provider about your progress
US$ 21.80
US$ 21.49
US$ 29.03
US$ 21.13
US$ 29.44
US$ 28.57
